EIKN
Eikon Therapeutics, Inc.
7.30$
-1.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|
| – | +30.8% | -7.4% | +43.1% | -8.4% | |
| – | +71.4% | -10.6% | +51.8% | +3.3% | |
| – | -18.8% | +0.0% | +54.0% | -11.5% | |
| – | – | -10.6% | +52.6% | +3.7% | |
| – | +36.1% | +1.9% | -79.6% | +4.3% | |
| – | -21.4% | +23.9% | -18.1% | +22.7% | |
| – | – | +1.2% | -2.9% | -3.0% | |
| – | -75.6% | -84.1% | +781.8% | +9.3% | |
| – | – | – | – | -15.3% | |
| – | – | – | – | – | |
| – | +0.0% | +0.3% | +0.0% | +0.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.